News for hackers. Stuff that matters.
Re:Theranos Trouble: A First Person Account by semi-extrinsic on Sunday October 18, 2015 @03:15PM (#10409376)
It appears that most tests done by Theranos are using the same techniques as any other lab, so naturally the variances would be similar. The only test their Edison machine is FDA approved for is herpes simplex. They have caught some flak, however, for allegedly diluting blood samples before standard analysis.
Re:Theranos Trouble: A First Person Account by djhn on Sunday October 18, 2015 @04:20PM (#10409632)
What ends would diluting it achieve?
Re:Theranos Trouble: A First Person Account by dekhn on Sunday October 18, 2015 @04:48PM (#10409727)
Basically, the story is this: 1) The founder of Theranos is afraid of blood

2) Theranos invents a new low volume blood draw technology and test mechanism (which contains many subtests)

3) The test they use to augment their limited test is a commercial product that works on larger volumes of blood

4) because their test doesn't actually work all that well (I actually don't know enough about this part, as their work is mostly secret) they have to pivot a bunch of of their tests to using a different company's test machine

5) Those other commercial products actually do work with smaller volumes of blood, diluted to larger volumes, in case you can't get a large volume from a patient

There isn't anything wrong with Theranos diluting blood to make their tests work with another commercial product (this is a legitimate use). However, it does seem to suggest that the technology that hyped Theranos up to a multibillion value isn't as good as was claimed; instead, Theranos is mostly just another conventional provider of diagnostic tests. If they're just another conventional provider, it sort of kills the whole startup story and investment, because why would you invest in a disruptor if you can make money from the establishment?

That said, it's common to see startups start with a really ambitious goal, fail, then pivot to become more conventional companies with decent but not spectacular revenue streams.

Re:Theranos Trouble: A First Person Account by kzhahou on Sunday October 18, 2015 @05:31PM (#10409876)
> because their test doesn't actually work all that well (I actually don't know enough about this part, as their work is mostly secret) they have to pivot a bunch of of their tests to using a different company's test machine

This is like if every time you fetched an Uber, a yellow cab showed up! Except for one market out of 200, where they run five black cars, in a small SF neighborhood.

Re:Theranos Trouble: A First Person Account by dekhn on Sunday October 18, 2015 @06:40PM (#10410145)
yes, that is how 95% of startups that don't go out of business end up. also, the yellow cab has a little black hoodie that makes it look like a limo.
Re:Theranos Trouble: A First Person Account by jkimmel on Sunday October 18, 2015 @04:45PM (#10409717)
They take smaller blood draws from finger tip pricks that aren't large enough in volume to run on a standard machine from Siemens et al.

To get around this, they supposedly dilute the samples to a point where the concentrations of analytes are well below the machines minimum operating specifications.

Re:Theranos Trouble: A First Person Account by dekhn on Sunday October 18, 2015 @05:26PM (#10409854)
Theranos responded that they use the exact manufacturer dilution protocol on their volumes. I don't know of any fact-based article saying they were operating the machines below their minimum specs.
Re:Theranos Trouble: A First Person Account by daughart on Monday October 19, 2015 @04:42PM (#10415574)
My understanding is that only the Edison machine uses finger prick amounts. However, it sounds like since these machines don't work they are using standard instruments. For these they take venous blood draws, just using a child-sized vacuum tube instead of an adult-sized vacuum tube. She talked about using the child-sized vacuum tubes in an interview. Not really a big differentiator in my opinion.